Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (23)
Krishan R. Jethwa, Ed Kim, Jordan Berlin, Christopher J. Anker, Leila Tchelebi, Gerard Abood, Christopher L. Hallemeier, Salma Jabbour, Timothy Kennedy, Rachit Kumar, Percy Lee, Navesh Sharma, William Small, Vonetta Williams & Suzanne Russo. (2024) Executive Summary of the American Radium Society Appropriate Use Criteria for Neoadjuvant Therapy for Nonmetastatic Pancreatic Adenocarcinoma. American Journal of Clinical Oncology 47:4, pages 185-199.
Crossref
Crossref
Eugene J. Koay, Mohamed Zaid, Maureen Aliru, Polycarpe Bagereka, Arie Van Wieren, Maria Jovie Rodriguez, Galia Jacobson, Robert A. Wolff, Michael Overman, Gauri Varadhachary, Shubham Pant, Huamin Wang, Ching-Wei Tzeng, Naruhiko Ikoma, Michael Kim, Jeffrey E. Lee, Matthew HG. Katz, Eric Tamm, Priya Bhosale, Cullen M. Taniguchi, Emma B. Holliday, Grace L. Smith, Ethan B. Ludmir, Bruce D. Minsky, Christopher H. Crane, Albert C. Koong, Prajnan Das, Xuemei Wang, Milind Javle & Sunil Krishnan. (2022) Nab-Paclitaxel, Capecitabine, and Radiation Therapy After Induction Chemotherapy in Treating Patients With Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase 1 Trial and Imaging-based Biomarker Validation. International Journal of Radiation Oncology*Biology*Physics 114:3, pages 444-453.
Crossref
Crossref
Joshua P. Schiff, Alex T. Price, Hayley B. Stowe, Eric Laugeman, Re-I Chin, Casey Hatscher, Eleanor Pryser, Bin Cai, Geoffrey D. Hugo, Hyun Kim, Shahed N. Badiyan, Clifford G. Robinson & Lauren E. Henke. (2022) Simulated computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of locally advanced pancreatic cancer. Radiotherapy and Oncology 175, pages 144-151.
Crossref
Crossref
Kenichi Matsumoto, Akihiko Miyamoto, Tomoya Kawase, Taro Murai & Yuta Shibamoto. (2021) Concurrent high-dose intensity-modulated radiotherapy and chemotherapy for unresectable locally advanced and metastatic pancreatic cancer: a pilot study. Journal of Radiotherapy in Practice 21:2, pages 239-244.
Crossref
Crossref
M. Rouffiac, S. Ghirardi, C. Chevalier, I. Bessières, K. Peignaux-Casasnovas, G. Truc & G. Créhange. (2021) Radiothérapie hypofractionnée extrême du cancer du pancréas. Cancer/Radiothérapie 25:6-7, pages 692-698.
Crossref
Crossref
Antoine Schernberg, Dewi Vernerey, David Goldstein, Jean-Luc Van Laethem, Bengt Glimelius, Paul van Houtte, Franck Bonnetain, Christophe Louvet, Pascal Hammel & Florence Huguet. (2021) Predictive Value of Neutrophils Count for Local Tumor Control After Chemoradiotherapy in Patients With Locally Advanced Pancreatic Carcinoma. International Journal of Radiation Oncology*Biology*Physics 110:4, pages 1022-1031.
Crossref
Crossref
David P. Horowitz, Karyn Goodman & Lisa A. Kachnic. (2021) Ablative Radiotherapy for Patients With Inoperable Pancreas Cancer—Ready for Prime Time?. JAMA Oncology 7:5, pages 687.
Crossref
Crossref
Sarah Stefanowicz, Waldemar Wlodarczyk, Susanne Frosch, Sebastian Zschaeck & Esther G.C. Troost. (2021) Dose-escalated simultaneously integrated boost photon or proton therapy in pancreatic cancer in an in-silico study: Gastrointestinal organs remain critical. Clinical and Translational Radiation Oncology 27, pages 24-31.
Crossref
Crossref
Comron Hassanzadeh, Soumon Rudra, Ani Bommireddy, William G. Hawkins, Andrea Wang-Gillam, Ryan C. Fields, Bin Cai, Justin Park, Olga Green, Michael Roach, Lauren Henke & Hyun Kim. (2021) Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation. Advances in Radiation Oncology 6:1, pages 100506.
Crossref
Crossref
Joseph Abi Jaoude, Ramez Kouzy, Nicholas D. Nguyen, Daniel Lin, Sonal S. Noticewala, Ethan B. Ludmir & Cullen M. Taniguchi. (2020) Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies. Current Problems in Cancer 44:6, pages 100607.
Crossref
Crossref
X. Chen-Zhao, O. Hernando, M. López, E. Sánchez, A. Montero, M. García-Aranda, R. Ciérvide, J. Valero, R. Alonso, J. M. Cárdenas-Rebollo, E. Vicente, Y. Quijano, A. Cubillo, R. Álvarez, S. Prados, C. Plaza, J. García, D. Zucca, P. Fernández-Letón & C. Rubio. (2020) A prospective observational study of the clinical and pathological impact of stereotactic body radiotherapy (SBRT) as a neoadjuvant strategy of chemoradiation in pancreatic cancer. Clinical and Translational Oncology 22:9, pages 1499-1505.
Crossref
Crossref
Christelle Bouchart, Julie Navez, Jean Closset, Alain Hendlisz, Dirk Van Gestel, Luigi Moretti & Jean-Luc Van Laethem. (2020) Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?. Therapeutic Advances in Medical Oncology 12, pages 175883592093609.
Crossref
Crossref
Seiji Natsume, Yasuhiro Shimizu, Yoshiki Senda, Susumu Hijioka, Keitaro Matsuo, Seiji Ito, Koji Komori, Tetsuya Abe & Kazuo Hara. (2019) Conversion surgery only for highly selected patients with unresectable pancreatic cancer: a satisfactory outcome in exchange for a lower resection rate. Surgery Today 49:8, pages 670-677.
Crossref
Crossref
Soumon Rudra, Naomi Jiang, Stephen A. Rosenberg, Jeffrey R. Olsen, Michael C. Roach, Leping Wan, Lorraine Portelance, Eric A. Mellon, Anna Bruynzeel, Frank Lagerwaard, Michael F. Bassetti, Parag J. Parikh & Percy P. Lee. (2019) Using adaptive magnetic resonance image‐guided radiation therapy for treatment of inoperable pancreatic cancer. Cancer Medicine 8:5, pages 2123-2132.
Crossref
Crossref
John M. David, Sungjin Kim, Veronica R. Placencio-Hickok, Arman Torosian, Andrew Hendifar & Richard Tuli. (2019) Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers. Advances in Radiation Oncology 4:2, pages 302-313.
Crossref
Crossref
Sarah Stefanowicz, Kristin Stützer, Sebastian Zschaeck, Annika Jakobi & Esther G. C. Troost. (2018) Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer. Radiation Oncology 13:1.
Crossref
Crossref
Aida Cristina Rahy-Martín, Francisco Cruz-Benavides, Mar Sánchez-Lauro, Álvaro Rodríguez-Méndez, Íñigo San Miguel, Pedro Lara & Joaquín Marchena-Gómez. (2018) Radioterapia intraoperatoria con Intrabeam® para el tratamiento del adenocarcinoma de páncreas resecable. Cirugía Española 96:8, pages 482-487.
Crossref
Crossref
Aida Cristina Rahy-Martín, Francisco Cruz-Benavides, Mar Sánchez-Lauro, Álvaro Rodríguez-Méndez, Íñigo San Miguel, Pedro Lara & Joaquín Marchena-Gómez. (2018) Intraoperative Radiotherapy With the Intrabeam® Device for the Treatment of Resectable Pancreatic Adenocarcinoma. Cirugía Española (English Edition) 96:8, pages 482-487.
Crossref
Crossref
Eun Sang Oh, Tae Hyun Kim, Sang Myung Woo, Woo Jin Lee, Ju Hee Lee, Sang Hee Youn, Sung Sik Han, Sang Jae Park & Dae Yong Kim. (2018) Effectiveness and feasibility of concurrent chemoradiotherapy using simultaneous integrated boost-intensity modulated radiotherapy with and without induction chemotherapy for locally advanced pancreatic cancer. Radiation Oncology Journal 36:3, pages 200-209.
Crossref
Crossref
Anna Torgeson, Shane Lloyd, Dustin Boothe, Randa Tao, Jonathan Whisenant, Ignacio Garrido‐Laguna & George M. Cannon. (2017) Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer. Cancer 123:19, pages 3816-3824.
Crossref
Crossref
Eunsung Jun, Song Cheol Kim, Chan Mi Lee, Juyun Oh, Song Lee & In Kyong Shim. (2017) Synergistic effect of a drug loaded electrospun patch and systemic chemotherapy in pancreatic cancer xenograft. Scientific Reports 7:1.
Crossref
Crossref
Xing Chen, Geng Liu, Kaiqiang Wang, Guodong Chen & Jinjin Sun. (2017) Neoadjuvant radiation followed by resection versus upfront resection for locally advanced pancreatic cancer patients: a propensity score matched analysis. Oncotarget 8:29, pages 47831-47840.
Crossref
Crossref
J. Taieb, A.-L. Pointet, J.L. Van Laethem, B. Laquente, S. Pernot, F. Lordick & M. Reni. (2017) What treatment in 2017 for inoperable pancreatic cancers?. Annals of Oncology 28:7, pages 1473-1483.
Crossref
Crossref